Back | Next |
home / stock / btai / btai message board
Subject | By | Source | When |
---|---|---|---|
Chugging down due to hawkish fed | Alan Brown | investorshub | 02/10/2023 1:09:07 AM |
$BTAI is chugging right along. | MDizzle | investorshub | 01/12/2023 1:56:54 PM |
First Patients Dosed in SERENITY III Phase 3 | MDizzle | investorshub | 11/30/2022 11:40:12 PM |
BioXcel Therapeutics Q3 EPS $(1.49) Misses $(1.35) Estimate, | realfast95 | investorshub | 11/10/2022 12:42:02 PM |
BofA lowers PT $BTAI $46 (was $52)Buy /Rev/EPS | realfast95 | investorshub | 08/10/2022 10:29:46 AM |
As of June 30, 2022, cash and cash | realfast95 | investorshub | 08/09/2022 11:45:27 AM |
BioXcel Therapeutics Reports Second Quarter 2022 Financial Results | realfast95 | investorshub | 08/09/2022 11:44:30 AM |
BioXcel Therapeutics Q2 EPS $(1.35) Misses $(1.22) Estimate | realfast95 | investorshub | 08/09/2022 11:43:03 AM |
Mizuho Securities Initiates a Buy Rating on Bioxcel | realfast95 | investorshub | 08/04/2022 10:53:18 AM |
is $BTAI in the$ XBI index? | realfast95 | investorshub | 07/27/2022 11:32:59 AM |
Notice of Allowance received from USPTO | lettruthringout | investorshub | 07/24/2022 9:57:47 PM |
PIP approved by EMA | lettruthringout | investorshub | 07/21/2022 4:39:04 PM |
gap closed | realfast95 | investorshub | 07/11/2022 1:35:15 PM |
previous close 15.85 that had a gap to | realfast95 | investorshub | 07/07/2022 6:54:24 PM |
took profits | realfast95 | investorshub | 07/07/2022 4:22:15 PM |
Igalmi now available! | lettruthringout | investorshub | 07/06/2022 11:40:20 PM |
$BTAI Initiated @ Mizuho with a BUY $19 | realfast95 | investorshub | 07/06/2022 10:12:18 PM |
Patience pays off. Finally green in a treacherous market. | realfast95 | investorshub | 07/06/2022 2:29:03 PM |
On July 6, 2022, BioXcel Therapeutics, Inc. (the | realfast95 | investorshub | 07/06/2022 1:22:32 PM |
BioXcel Therapeutics Appoints Michael P. Miller to Board | realfast95 | investorshub | 07/05/2022 11:51:21 AM |
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
BioXcel Therapeutics Inc. Website:
Study achieved its objective and demonstrated no evidence of tachyphylaxis, tolerance, or withdrawal with 180 mcg dose (highest approved dose) For each episode occurring over seven days, a reduction in agitation was observed and no serious adverse events were reported following treatmen...
NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that CEO Vimal Mehta, Ph.D., will present at the Jef...
NEW HAVEN, Conn., May 21, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that Rob Risinger, M.D., Chief Medical Officer ...